The Growing Body of Evidence for the Treatment of a Broader Population of Patients with DMD
Released On
June 20, 2025
Expires On
June 19, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Neurology
Topic(s)
Muscular Dystrophy
Providers/Grant Support
This activity is supported by an independent education grant from Sarepta Therapeutics.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Nursing Contact Hours
- PAs — maximum of 1.0 AAPA Category 1 CME credits
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This educational activity is intended for health care professionals involved in the management of patients with Duchenne Muscular Dystrophy, including neurologists and other neuromuscular specialists.
Program Overview
By completing this activity, learners will gain the skills and confidence to determine therapeutic candidacy and conduct appropriate assessments for patients with Duchenne Muscular Dystrophy (DMD) across the age spectrum, including older and non-ambulatory individuals. They will improve their ability to interpret and apply the latest clinical data to real-world scenarios and make informed decisions about treatment and monitoring. Through case-based education, learners will enhance their competence in aligning patients to appropriate therapies and managing long-term care in a rapidly evolving treatment landscape.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate real-world, case-based scenarios for patients with DMD to help determine therapeutic candidacy across the age spectrum
- Assess the latest data from clinical studies with DMD treatments to help inform clinical decision-making
- Describe best practices for the ongoing monitoring of patients at various ages who are receiving treatment for DMD
Faculty
Crystal Proud, MD (Chair)
Pediatric Neurology
Children’s Hospital of the King’s Daughters
Norfolk, VA
Erika Finanger, MD, MS
Pediatric Neurologist
OHSU Doernbecher Children’s Hospital
Portland, OR
Accreditation Statement
In support of improving patient care, The France In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians
The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The France Foundation designates this activity for 1.0 contact hours.
Physician Associates
The France Foundation has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until June 19, 2026. PAs should only claim credit commensurate with the extent of their participation.
All other health care professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest
Instructions for Participation and Credit
There are no fees for participating in and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures
- Participate in the online activity
- Submit the evaluation form
Certificates will be available in your transcript.
Course Viewing Requirements
Supported Browsers (Desktop/Mobile)
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, and Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The France Foundation requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
For CME questions please contact: [email protected] .